[1]邱英鹏赵羽西赵翔肖月.澳大利亚假体类高值医用耗材医保准入管理经验及启示[J].中国卫生质量管理,2021,28(05):012-15.[doi:10.13912/j.cnki.chqm.2021.28.5.04 ]
 QIU Yingpeng,ZHAO Yuxi,ZHAO Xiang.Experience in Medical Insurance Access Management of Prosthetic High Value Medical Consumables in Australia and Its Implications[J].Chinese Health Quality Management,2021,28(05):012-15.[doi:10.13912/j.cnki.chqm.2021.28.5.04 ]
点击复制

澳大利亚假体类高值医用耗材医保准入管理经验及启示
分享到:

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R]

卷:
第28卷
期数:
2021年05期
页码:
012-15
栏目:
特别关注
出版日期:
2021-05-28

文章信息/Info

Title:
Experience in Medical Insurance Access Management of Prosthetic High Value Medical Consumables in Australia and Its Implications
作者:
邱英鹏赵羽西赵翔肖月
国家卫生健康委卫生发展研究中心
Author(s):
QIU YingpengZHAO YuxiZHAO Xiang
China National Health Development Research Center
关键词:
澳大利亚假体类高值医用耗材医保准入卫生技术评估
Keywords:
AustraliaProsthesesHigh Value Medical Consumables Medical Insurance AccessHealth Technology Assessment
分类号:
R197.39;TH77
DOI:
10.13912/j.cnki.chqm.2021.28.5.04
文献标志码:
A
摘要:
目的分析澳大利亚假体类高值医用耗材医保准入管理经验,为我国医保部门建立相关机制提供参考。方法访问澳大利亚卫生部官方网站,检索《假体类医用耗材目录》管理相关政策、文件和指南,并进行信息提取。结果澳大利亚《假体类医用耗材目录》管理包括申报材料及证据提交、评估、评审及决策四大步骤。在基于综合价值判断进行准入和支付政策制定过程中,卫生技术评估(HTA)提供了重要的循证证据。结论我国医保部门可参考澳大利亚高值医用耗材管理经验,建立以价值为基础,以卫生技术评估为支持,经第三方委员会独立评审的高值医用耗材准入机制。
Abstract:
ObjectiveTo analyze the medical insurance access management experience of high value medical consumables for prostheses in Australia, and to provide reference for the establishment of relevant mechanism for medical insurance departments in China.MethodsBy visiting the official website of the Australian Ministry of Health, the relevant policies, documents and guidelines for management of Prosthetic Medical Consumables List were retrieved and the information was extracted.ResultsThe management of Australian Prosthetic Medical Consumables List included four steps: submission of application materials and evidence, evaluation, review and decision.Health technology assessment (HTA) provided important evidence-based evidence in the development of access and payment policies based on comprehensive value judgments.Conclusion The medical insurance department in China can refer to the management experience of high value medical consumables in Australia, and establish the access system of high value medical consumables which is based on value and supported by HTA and independently reviewed by the third-party committee.

参考文献/References:

[1]高荣伟.澳大利亚的医疗保险制度[J].检察风云,2018(15):54-55. [2]冯鹏程. 澳大利亚商业健康保险剖析[N].中国保险报,2016-01-13(8). [3]The Department of Health Australia.The prostheses list[EB/OL].(2020-10-28)[2020-11-20].https://www1.health.gov.au/internet/main/publishing.nsf/Content/health-privatehealth-prostheseslist.htm. [4]The Department of Health Australia.Cover for prostheses[EB/OL].(2020-10-22)[2020-11-20].https://www.health.gov.au/health-topics/private-health-insurance/what-private-health-insurance-covers/prostheses-cover-under-private-health-insurance. [5]殷伊蓉, 常峰, 吕梦凝. 日本与澳大利亚的医用耗材定价和补偿机制分析及启示[J].中国卫生经济,2017,36(10):42-45. [6]The Department of Health Austral.About the Prostheses List Advisory Committee(PLAC)[EB/OL].(2016-10-19)[2020-11-20 ].https://www.health.gov.au/resources/publications/prostheses-list-advisory-committee-plac-terms-of-reference. [7]The Department of Health Austral. About the clinical advisory groups[EB/OL].(2019-10-30)[2020-11-20].https://www.health.gov.au/committees-and-groups/clinical-advisory-groups-cags. [8]茅艺伟,陈英耀,唐檬,等.澳大利亚卫生技术评估的应用[J].中国卫生资源,2014,17(6):484-486. [9]The Department of Health Austral. Prostheses List Management System(PLMS)[EB/OL].(2019-10-30)[2020-11-20].http://prostheses.health.gov.au/wps/portal/register. [10]Guide to listing and setting benefits for prostheses[EB/OL].(2020-02-19)[2020-11-20].https://www.health.gov.au/resources/publications/prostheses-list-guide. [11]杨建龙.我国高值医用耗材医保准入管理探究[J].中国医疗保险,2020(8):17-21.

相似文献/References:

[1]司令 张雪 王聪 邢佳音 王鑫淼.澳大利亚医院暴力防范对策及启示[J].中国卫生质量管理,2016,23(06):104.[doi:10.13912/j.cnki.chqm.2016.23.6.34]
[2]张曙欣 陈校云 冯力 宋杨杨 胡可慧 黄婉茹 裴治纲.澳大利亚和新西兰新兴卫生技术水平扫描网络的实践与启示[J].中国卫生质量管理,2019,26(02):106.[doi:10.13912/j.cnki.chqm.2019.26.2.31]

更新日期/Last Update: 2021-05-28